Bone and Mineral Metabolism Disorders

Top Story

Veverimer demonstrates benefits in metabolic acidosis for patients with CKD, diabetes

March 28, 2020

PHREEDOM study: Tenapanor effective for hyperphosphatemia in patients on dialysis

December 4, 2019
Phase 3 results from the PHREEDOM study demonstrated treatment with tenapanor safely and effectively decreased serum phosphorous in patients with chronic kidney disease…
Meeting News

Velphoro effective in reducing phosphorus in new patients on dialysis

December 3, 2019
WASHINGTON — Use of the sucroferric oxyhydroxide binder by Fresenius Medical Care Renal Therapies Group, Velphoro, was effective in lowering serum phosphorus…
Meeting News

Patiromer controlled serum potassium in patients with CKD on renin-angiotensin-aldosterone system inhibitors

November 19, 2019
WASHINGTON — Patiromer was effective in controlling serum potassium in hyperkalemic patients with diabetes and advanced kidney disease on…
More Headlines »
Feature Article

A Framework for Approaching Refractory Hypocalcemia in Children

Pediatric Annals, May 2019, Volume 48 Issue 5
Hypocalcemia is a potentially fatal electrolyte imbalance with complications that include seizures, tetany, prolonged…
More »